Anti-TOMM7 monoclonal antibody

Pre-made anti-TOMM7 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to TOMM7/TOMM7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2162-Ab-1/ GM-Tg-hg-IP2162-Ab-2Anti-Human TOMM7 monoclonal antibodyHuman
GM-Tg-rg-IP2162-Ab-1/ GM-Tg-rg-IP2162-Ab-2Anti-Rat TOMM7 monoclonal antibodyRat
GM-Tg-mg-IP2162-Ab-1/ GM-Tg-mg-IP2162-Ab-2Anti-Mouse TOMM7 monoclonal antibodyMouse
GM-Tg-cynog-IP2162-Ab-1/ GM-Tg-cynog-IP2162-Ab-2Anti-Cynomolgus/ Rhesus macaque TOMM7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2162-Ab-1/ GM-Tg-felg-IP2162-Ab-2Anti-Feline TOMM7 monoclonal antibodyFeline
GM-Tg-cang-IP2162-Ab-1/ GM-Tg-cang-IP2162-Ab-2Anti-Canine TOMM7 monoclonal antibodyCanine
GM-Tg-bovg-IP2162-Ab-1/ GM-Tg-bovg-IP2162-Ab-2Anti-Bovine TOMM7 monoclonal antibodyBovine
GM-Tg-equg-IP2162-Ab-1/ GM-Tg-equg-IP2162-Ab-2Anti-Equine TOMM7 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2162-Ab-1/ GM-Tg-hg-IP2162-Ab-2; GM-Tg-rg-IP2162-Ab-1/ GM-Tg-rg-IP2162-Ab-2;
GM-Tg-mg-IP2162-Ab-1/ GM-Tg-mg-IP2162-Ab-2; GM-Tg-cynog-IP2162-Ab-1/ GM-Tg-cynog-IP2162-Ab-2;
GM-Tg-felg-IP2162-Ab-1/ GM-Tg-felg-IP2162-Ab-2; GM-Tg-cang-IP2162-Ab-1/ GM-Tg-cang-IP2162-Ab-2;
GM-Tg-bovg-IP2162-Ab-1/ GM-Tg-bovg-IP2162-Ab-2; GM-Tg-equg-IP2162-Ab-1/ GM-Tg-equg-IP2162-Ab-2
Products NameAnti-TOMM7 monoclonal antibody
Formatmab
Target NameTOMM7
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-TOMM7 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2162-Ag-1Recombinant multi-species TOM7/ TOMM7 protein
    ORF Viral VectorvGMLP003832human TOMM7 Lentivirus particle
    ORF Viral VectorpGMLP003832human TOMM7 Lentivirus plasmid
    ORF Viral VectorpGMLPm003248mouse Tomm7 Lentivirus plasmid
    ORF Viral VectorvGMLPm003248mouse Tomm7 Lentivirus particle


    Target information

    Target IDGM-IP2162
    Target NameTOMM7
    Gene ID54543,66169,685620,705701,482351,102899863,614074,100630688
    Gene Symbol and Synonyms1110020J08Rik,TOM7,TOMM7
    Uniprot AccessionQ9P0U1,Q2KI08
    Uniprot Entry NameTOM7_HUMAN,TOM7_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000196683
    Target ClassificationN/A

    The target: TOMM7, gene name: TOMM7, also named as TOM7. This gene encodes a subunit of the translocase of the outer mitochondrial membrane. The encoded protein regulates the assembly and stability of the translocase complex. [provided by RefSeq, Oct 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.